Analytical chemistry · 2026
Ion-Driven Cyclic Hotspot Modulation for Tunable SERS Detection of Alpha-Fetoprotein.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bao Meiqi, Zhang Ling, Liu Hongcai, Fu Cuicui, Zhao Chunfang, Ma Xiaoyan, Wang Huiting, Zhang Qian, Jiang Yi, Yan Lihui, Xia Jiarui
Аннотация
Accurate detection of alpha-fetoprotein (AFP) is vital for early cancer diagnosis, yet traditional immunoassays suffer from limited sensitivity. Although surface-enhanced Raman scattering (SERS) is a formidable analytical tool, existing platforms often encounter a performance saturation bottleneck upon reaching equilibrium, lacking a controllable regulation mechanism capable of guiding the stepwise intensification of hotspots for continuous gain throughout the analytical process. This work proposes a metal-ion-mediated cyclic amplification strategy. Inspired by coordination chemistry, aluminum ions (Al3+) serve as highly specific "molecular glues" that coordinate with the surface ligands of His/4-MBA-functionalized gold nanoparticles (His/4-MBA@Au NPs) to trigger their controlled aggregation. By iteratively introducing these Al3+ ions and functionalized Au NPs onto a solid-phase immunocomplex, we achieved a stepwise, programmable densification of 3D SERS hotspots. Unlike conventional "single-trigger" modes, this multicycle process allows for the evolutionary growth of assay performance, where hotspot tunability is realized by adjusting the number of cycles: initial stages (Cycle 1) provide a broad dynamic range, while highly densified hotspot architectures (Cycle 5) deliver superior ultratrace sensitivity. Consequently, the limit of detection (LOD) for the target AFP improved progressively from 8.6 pg·mL-1 in Cycle 1 down to an ultimate 0.043 pg·mL-1 in Cycle 5. This strategy exhibits excellent anti-interference capability in human serum, offering a versatile blueprint for ultratrace biomarker detection.